Thøger Gorm Jensen

Thøger Gorm Jensen serves as a Guest researcher at the Research Unit for Clinical Microbiology within the Clinical Institute at Odense University Hospital (OUH), affiliated with the University of Southern Denmark (SDU). His academic career spans clinical microbiology research with particular emphasis on bloodstream infections, bacterial genomics, and epidemiological surveillance systems. His work bridges laboratory research with practical clinical applications in hospital infection control and public health monitoring.

Dr. Jensen's research interests focus on the epidemiology of bloodstream infections, particularly bacteremia in Danish populations. His work encompasses molecular characterization of pathogens, development of diagnostic pipelines like RSYD-BASIC for bacterial isolate analysis, and comparative studies of infection patterns across different populations. He has made significant contributions to understanding SARS-CoV-2 dynamics during the pandemic and continues to investigate antimicrobial resistance patterns in clinically relevant pathogens. His research integrates genomic approaches with traditional epidemiological methods to provide comprehensive insights into infection dynamics.

Analysis of his recent publication trends (2021-2025) reveals a strong focus on population-based cohort studies of bloodstream infections in Denmark, with increasing emphasis on comparative international epidemiology (particularly with Singapore) and the implementation of automated surveillance systems. His work consistently addresses clinically relevant questions about pathogen identification, antimicrobial resistance patterns, and infection control measures, with practical applications in hospital settings and national public health infrastructure.

Dr. Jensen has been actively involved in developing diagnostic tools and surveillance systems, including landmark corona tests during the pandemic as reported in multiple media outlets. His research has practical implications for clinical microbiology laboratories and hospital infection control protocols, with several publications focusing on how laboratories can act proactively in implementing rapid diagnostics for early clinical decision making.

His collaborative network extends across Danish hospitals and international institutions, with notable involvement in the SG-DK Bacteraemia study group and contributions to nationwide surveillance initiatives. Dr. Jensen participates in significant research activities including conference presentations on bacterial whole genome sequencing implementation and PCR diagnostic optimization, demonstrating his commitment to advancing clinical microbiology practice through research.